Get in touch
Tell us the programme you're building and we'll map the integration with you.
Book a 30-min discovery callAbout Remi Health
Diagnostics shouldn't be the hardest part of building a health brand.
Remi Health is the infrastructure that lets health, longevity, and pharma companies embed lab-grade diagnostics into their own products, without building a lab, logistics, or regulatory stack themselves.
- Multiple European markets
- Accredited partner labs
- One integration
What we do
One integration.
The entire diagnostics stack.
Remi Health is a Diagnostics-as-a-Service platform used by payers, digital health companies, longevity companies, pharma companies, and healthcare providers to embed diagnostics into their products through a single integration. Operating across multiple European markets, Remi Health partners with leading laboratories and combines decentralised collection, lab connectivity, regulatory compliance, medical oversight, and digital patient experiences into one scalable solution.
Decentralised Collection
At-home and on-site sampling, kitted and tracked.
Lab Connectivity
Accredited European laboratories on one interface.
Regulatory Compliance
DSGVO and IVDR handled inside the platform.
Medical Oversight
Physician review and validated result delivery.
Digital Patient Experiences
Ordering, tracking and results under your brand.
Why we exist
Diagnostics shouldn't require building a lab.
Every health brand that wants to offer diagnostics runs into the same wall: a lab, logistics, medical oversight, and compliance work that has nothing to do with their actual product. Building it alone takes months, per market, per regulation. Anthony and Marvin started Remi Health to remove that wall: one integration that connects any brand to a network of leading European laboratories, so testing becomes a feature they can launch in weeks, not a company they have to build.
Market signal
8.3%
Self-sampling CAGR
5.4%
Diagnostics market
Self-sampling is growing faster than the diagnostics market itself: 8.3% vs. 5.4% CAGR to 2030. The only question is whether that demand reaches people through infrastructure built for it, or not at all.
Funding
Backed to build European diagnostics infrastructure.
In March 2026 we closed an oversubscribed €3 million seed round, bringing total funding to €5 million. The round was led by IBB Ventures, with participation from Catalpa Ventures, the MSD Global Health Innovation Fund, and our existing pre-seed business angels. The capital goes into expanding the cross-border laboratory network and the platform behind it.
€3M
Seed round, oversubscribed
€5M
Total funding to date
1M+
Diagnostic tests processed
2026
Round announced in March
Investors
- IBB Ventures
- Catalpa Ventures
- MSD Global Health Innovation Fund
- Pre-seed business angels
Team
Based in Berlin.
- Anthony Bielenstein · co-founder
- André Lange · CTO
- Marvin Abert · co-founder
What we believe
How we build.
Compliance is the foundation, not a feature.
DSGVO, IVDR, medical oversight, built in from day one, not bolted on later.
Infrastructure, not spectacle.
We stay invisible so our partners' brands stay front and center.
Speed without cutting corners.
Weeks to launch, medical-grade every step of the way.
Built for scale from day one.
One integration, designed to work across every market we enter.
Careers
We're hiring.
Join a team building diagnostics infrastructure for Europe.